{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:37:46Z","timestamp":1778107066924,"version":"3.51.4"},"reference-count":144,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ccm.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T16:30:29Z","timestamp":1382027429000},"page":"739-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pulmonary Hypertension Associated with Chronic Hemolytic Anemia and Other Blood Disorders"],"prefix":"10.1016","volume":"34","author":[{"given":"Roberto F.","family":"Machado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2013.08.006_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.279.3.217","article-title":"Human cardiovascular and metabolic response to acute, severe isovolemic anemia","volume":"279","author":"Weiskopf","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.08.006_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1172\/JCI101610","article-title":"The cardiac output in patients with chronic anemia as measured by the technique of right atrial catheterization","volume":"24","author":"Brannon","year":"1945","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccm.2013.08.006_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.10.5.653","article-title":"Hemodynamic studies in sickle cell anemia","volume":"10","author":"Leight","year":"1954","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.08.006_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.28.3.346","article-title":"Hemodynamic effects of chronic severe anemia","volume":"28","author":"Roy","year":"1963","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.08.006_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review","volume":"151","author":"Ashley-Koch","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(97)07330-3","article-title":"Sickle-cell disease","volume":"350","author":"Serjeant","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2013.08.006_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ajh.21162","article-title":"Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria","volume":"83","author":"Aliyu","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0950-3536(05)80066-6","article-title":"Sickle cell disease pathophysiology","volume":"6","author":"Noguchi","year":"1993","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib10","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ccm.2013.08.006_bib11","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib12","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccm.2013.08.006_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI10726","article-title":"Sickle cell anemia as an inflammatory disease","volume":"106","author":"Platt","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccm.2013.08.006_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1096\/fj.04-3218fje","article-title":"Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice","volume":"19","author":"Wood","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.ccm.2013.08.006_bib17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.freeradbiomed.2005.12.015","article-title":"Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction","volume":"40","author":"Wood","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.08.006_bib19","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.08.006_bib21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood-2007-12-126714","article-title":"Vascular dysfunction in a murine model of severe hemolysis","volume":"112","author":"Frei","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib23","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1378\/chest.116.suppl_1.92S","article-title":"Transgenic HbS mouse neutrophils in increased susceptibility to acute lung injury: implications for sickle acute chest syndrome","volume":"116","author":"Hsu","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2006.06110.x","article-title":"Pulmonary hypertension in patients with sickle cell disease: a longitudinal study","volume":"134","author":"Ataga","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajh.21058","article-title":"Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes","volume":"83","author":"De Castro","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.006_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A\u00a0hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jama.296.3.310","article-title":"N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease","volume":"296","author":"Machado","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2013.08.006_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2011.08777.x","article-title":"NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease","volume":"154","author":"Machado","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib30","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccm.2013.08.006_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","article-title":"Hemodynamic predictors of mortality in adults with sickle cell disease","volume":"187","author":"Mehari","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib33","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.032920","article-title":"Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom","volume":"124","author":"Sachdev","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.08.006_bib34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/pbc.20791","article-title":"Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease","volume":"47","author":"Ambrusko","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ccm.2013.08.006_bib35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3324\/haematol.11576","article-title":"Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension","volume":"92","author":"Liem","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/08880010601185892","article-title":"Pulmonary hypertension in sickle cell disease: relevance to children","volume":"24","author":"Kato","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ccm.2013.08.006_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.2007-0730","article-title":"Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease","volume":"121","author":"Pashankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ccm.2013.08.006_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00246-007-9018-x","article-title":"Pulmonary hypertension in children and adolescents with sickle cell disease","volume":"29","author":"Onyekwere","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","article-title":"Pulmonary hypertension and nitric oxide depletion in sickle cell disease","volume":"116","author":"Bunn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.21952","article-title":"Reconstructing sickle cell disease: a data-based analysis of the \u201chyperhemolysis paradigm\u201d for pulmonary hypertension from the perspective of evidence-based medicine","volume":"86","author":"Hebbel","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib42","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3324\/haematol.12632","article-title":"No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension","volume":"93","author":"van Beers","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","article-title":"Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy","volume":"142","author":"Westerman","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib44","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00001721-199504000-00001","article-title":"Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls","volume":"6","author":"Hagger","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ccm.2013.08.006_bib46","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","article-title":"Thrombophilia in sickle cell disease: the red cell connection","volume":"98","author":"Setty","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-130-6-199903160-00014","article-title":"Pulmonary hypertension after splenectomy?","volume":"130","author":"Hoeper","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02983382","article-title":"Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders","volume":"78","author":"Atichartakarn","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.1107","article-title":"Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency","volume":"67","author":"Chou","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<82::AID-AJH15>3.0.CO;2-B","article-title":"Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature","volume":"57","author":"Hayag-Barin","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02983790","article-title":"In\u00a0vivo platelet activation and hyperaggregation in hemoglobin E\/beta-thalassemia: a consequence of splenectomy","volume":"77","author":"Atichartakarn","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.20107","article-title":"Vasoactive factors in sickle cell disease: in\u00a0vitro evidence for endothelin-1-mediated vasoconstriction","volume":"76","author":"Ergul","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib53","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib54","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2141.2006.06417.x","article-title":"Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease","volume":"136","author":"Machado","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","article-title":"Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease","volume":"177","author":"Mekontso Dessap","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1099-0496(199710)24:4<277::AID-PPUL6>3.0.CO;2-H","article-title":"Lung function in infants with sickle cell disease","volume":"24","author":"Koumbourlis","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2013.08.006_bib58","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1067\/mpd.2001.111824","article-title":"Prevalence and reversibility of lower airway obstruction in children with sickle cell disease","volume":"138","author":"Koumbourlis","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccm.2013.08.006_bib59","first-page":"339","article-title":"Cardiorespiratory adjustments in chronic sickle cell anemia","volume":"19","author":"Lonsdorfer","year":"1983","journal-title":"Bull Eur Physiopathol Respir"},{"key":"10.1016\/j.ccm.2013.08.006_bib60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005792-198801000-00005","article-title":"Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure","volume":"67","author":"Powars","year":"1988","journal-title":"Medicine"},{"key":"10.1016\/j.ccm.2013.08.006_bib61","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.98.12051124","article-title":"Pulmonary function in sickle cell disease with or without acute chest syndrome","volume":"12","author":"Santoli","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.006_bib62","first-page":"509","article-title":"Lung function in sickle cell hemoglobinopathy patients compared with healthy subjects","volume":"80","author":"Young","year":"1988","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ccm.2013.08.006_bib63","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.200610-1498OC","article-title":"Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension","volume":"175","author":"Anthi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib64","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1164\/ajrccm.157.5.9710032","article-title":"Successful pulmonary thromboendarterectomy in two patients with sickle cell disease","volume":"157","author":"Yung","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib68","first-page":"452","article-title":"Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies","volume":"90","author":"Derchi","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Sildenafil therapy in patients with sickle disease and pulmonary hypertension","volume":"130","author":"Machado","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2141.2009.07906.x","article-title":"Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease","volume":"147","author":"Minniti","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib73","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4065\/78.10.1223","article-title":"Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment","volume":"78","author":"Koch","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ccm.2013.08.006_bib74","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/bmj.314.7095.1675","article-title":"The thalassaemias","volume":"314","author":"Weatherall","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ccm.2013.08.006_bib75","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.98.5.1138","article-title":"Cardiopulmonary assessment in beta-thalassemia major","volume":"98","author":"Grisaru","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-8703(97)70091-7","article-title":"Pulmonary hypertension in patients with thalassemia major","volume":"134","author":"Du","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccm.2013.08.006_bib77","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-8703(99)70129-8","article-title":"Pulmonary hypertension in patients with thalassemia major","volume":"138","author":"Derchi","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccm.2013.08.006_bib78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.2004.00304.x","article-title":"Cardiac status in well-treated patients with thalassemia major","volume":"73","author":"Aessopos","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2006.06053.x","article-title":"Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function","volume":"133","author":"Hagar","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib80","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","article-title":"Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia","volume":"127","author":"Aessopos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1378\/chest.107.1.50","article-title":"Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia","volume":"107","author":"Aessopos","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib82","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multicenter study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1196\/annals.1345.041","article-title":"Pulmonary hypertension in beta-thalassemia","volume":"1054","author":"Aessopos","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ccm.2013.08.006_bib84","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1537-2995.2007.01192.x","article-title":"Thalassemia intermedia today: should patients regularly receive transfusions?","volume":"47","author":"Aessopos","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.ccm.2013.08.006_bib85","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib86","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2003-09-3094","article-title":"Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E\/beta-thalassemia patient","volume":"103","author":"Atichartakarn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.2008.01192.x","article-title":"Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia","volume":"82","author":"Karimi","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3324\/haematol.2012.082065","article-title":"Sildenafil therapy in thalassemia patients with Doppler-defined risk for pulmonary hypertension","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib89","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2012-04-422568","article-title":"Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension","volume":"120","author":"Anthi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ajh.20603","article-title":"Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature","volume":"81","author":"Tam","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib91","series-title":"Hematology: basic principles and practice","first-page":"419","article-title":"Paroxysmal nocturnal hemoglobinuria","author":"Brodsky","year":"2005"},{"key":"10.1016\/j.ccm.2013.08.006_bib92","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1378\/chest.102.2.642","article-title":"Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria","volume":"102","author":"Heller","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib93","first-page":"1","article-title":"Clinical roundtable monograph: paroxysmal nocturnal hemoglobinuria: a case-based discussion","volume":"10","author":"Szer","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ccm.2013.08.006_bib94","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2012.09166.x","article-title":"Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function","volume":"158","author":"Hill","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib95","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","article-title":"Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria","volume":"149","author":"Hill","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib96","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib97","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib98","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1538-7836.2008.03024.x","article-title":"Delayed adverse vascular events after splenectomy in hereditary spherocytosis","volume":"6","author":"Schilling","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ccm.2013.08.006_bib99","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1444-0903.2004.00580.x","article-title":"Delayed pulmonary hypertension following splenectomy for congenital spherocytosis","volume":"34","author":"Jardine","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.ccm.2013.08.006_bib100","first-page":"84","article-title":"Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis","volume":"18","author":"Smedema","year":"2007","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.ccm.2013.08.006_bib101","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ajh.22182","article-title":"Prevalence of pulmonary hypertension in hereditary spherocytosis","volume":"86","author":"Crary","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib102","first-page":"48","article-title":"Pseudohyperkalaemia and pseudomacrocytosis caused by inherited red-cell disorders of the 'hereditary stomatocytosis' group","volume":"58","author":"Chetty","year":"2001","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.ccm.2013.08.006_bib103","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2613.1999.00120.x","article-title":"Temperature effects on cation transport in hereditary stomatocytosis and allied disorders","volume":"80","author":"Coles","year":"1999","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ccm.2013.08.006_bib104","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00000441-200510000-00008","article-title":"Pulmonary hypertension after splenectomy in hereditary stomatocytosis","volume":"330","author":"Yoshimoto","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ccm.2013.08.006_bib105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2141.1996.4881033.x","article-title":"Thrombo-embolic disease after splenectomy for hereditary stomatocytosis","volume":"93","author":"Stewart","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib106","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/bja\/aeg237","article-title":"Pulmonary thromboendarterectomy in a case of hereditary stomatocytosis","volume":"91","author":"Murali","year":"2003","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ccm.2013.08.006_bib107","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/HEM-120023377","article-title":"An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation","volume":"27","author":"Jais","year":"2003","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ccm.2013.08.006_bib108","unstructured":"Swerdlow SH, Campo E, Harris NL. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th edition. 2008."},{"key":"10.1016\/j.ccm.2013.08.006_bib109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000112822","article-title":"Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases","volume":"76","author":"Guilpain","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.ccm.2013.08.006_bib110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.leu.2404943","article-title":"Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status","volume":"22","author":"Cortelezzi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ccm.2013.08.006_bib111","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ajh.21178","article-title":"Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders","volume":"83","author":"Cortelezzi","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib112","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1080\/10428190701493928","article-title":"Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis","volume":"48","author":"Altintas","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ccm.2013.08.006_bib113","first-page":"1779","article-title":"Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"98","author":"Gupta","year":"2006","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.ccm.2013.08.006_bib114","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1164\/ajrccm.174.5.616","article-title":"Pulmonary arterial hypertension and chronic myeloproliferative disorders","volume":"174","author":"Di Stefano","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajh.20388","article-title":"Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea","volume":"80","author":"Ziakas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib116","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-143-6-200509200-00017","article-title":"New onset of myelofibrosis in association with pulmonary arterial hypertension","volume":"143","author":"Popat","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib117","first-page":"245","article-title":"Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"89","author":"Garypidou","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib118","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.120.3.801","article-title":"Unexplained pulmonary hypertension in chronic myeloproliferative disorders","volume":"120","author":"Dingli","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<130::AID-AJH8>3.0.CO;2-Z","article-title":"Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases","volume":"60","author":"Garcia-Manero","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1445-5994.1996.tb00642.x","article-title":"Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia","volume":"26","author":"Hill","year":"1996","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.ccm.2013.08.006_bib121","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajh.2830470320","article-title":"Pulmonary hypertension in polycythemia vera","volume":"47","author":"Nand","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib122","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1378\/chest.103.2.642","article-title":"Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia","volume":"103","author":"Marvin","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib123","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1183\/09031936.00175909","article-title":"Pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"35","author":"Adir","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.006_bib124","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera: myths, mechanisms, and management","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.00157707","article-title":"Pulmonary veno-occlusive disease in myeloproliferative disorders","volume":"33","author":"Willems","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.006_bib126","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.12426","article-title":"Angiogenesis in pulmonary hypertension with myelofibrosis","volume":"93","author":"Zetterberg","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ccm.2013.08.006_bib127","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2008.253","article-title":"Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation","volume":"22","author":"Landolfi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ccm.2013.08.006_bib128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ecoenv.2007.03.007","article-title":"Effects of discharges from the textile industry on the biotic integrity of benthic assemblages","volume":"69","author":"Gomez","year":"2008","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.ccm.2013.08.006_bib129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0761-8425(07)91070-0","article-title":"Pulmonary arterial hypertension due to tumor emboli","volume":"24","author":"Dot","year":"2007","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.ccm.2013.08.006_bib130","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1182\/blood-2005-08-3319","article-title":"High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension","volume":"107","author":"Popat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib131","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood-2006-02-005892","article-title":"Circulating CD34+ cells, pulmonary hypertension, and myelofibrosis","volume":"108","author":"Fadini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib132","first-page":"472","article-title":"Severe pulmonary hypertension in chronic idiopathic myelofibrosis","volume":"27","author":"Halank","year":"2004","journal-title":"Onkologie"},{"key":"10.1016\/j.ccm.2013.08.006_bib133","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.10075","article-title":"Whole-pulmonary low-dose radiation therapy in\u00a0agnogenic myeloid metaplasia with diffuse lung involvement","volume":"69","author":"Weinschenker","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib134","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2141.2002.03695.x","article-title":"Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia","volume":"118","author":"Steensma","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib135","first-page":"395","article-title":"Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension","volume":"13","author":"Haznedaroglu","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.ccm.2013.08.006_bib136","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2141.1984.tb02924.x","article-title":"Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders","volume":"57","author":"Hibbin","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ccm.2013.08.006_bib137","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary arterial hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ccm.2013.08.006_bib138","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/A:1010737409137","article-title":"Esophageal variceal ligation for esophageal variceal hemorrhage in a patient with portal and primary pulmonary hypertension complicating myelofibrosis","volume":"46","author":"Lee","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ccm.2013.08.006_bib139","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1378\/chest.10-0973","article-title":"71-year-old woman with myelofibrosis, hypoxemia, and pulmonary hypertension","volume":"138","author":"Trow","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2013.08.006_bib140","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V99.4.1144","article-title":"The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns","volume":"99","author":"Streiff","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2013.08.006_bib141","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccm.2013.08.006_bib142","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12288-010-0002-x","article-title":"Pulmonary hypertension in patients with hematological disorders following splenectomy","volume":"26","author":"Meera","year":"2010","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.ccm.2013.08.006_bib143","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/thx.2005.043216","article-title":"Pulmonary hypertension after splenectomy: a consequence of loss of the splenic filter or is there something more?","volume":"60","author":"Peacock","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2013.08.006_bib144","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:48:39Z","timestamp":1759452519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523113001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0272523113001068"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.006","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Hypertension Associated with Chronic Hemolytic Anemia and Other Blood Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}